Fes/Fps: A Key Regulator of Cell Growth, Differentiation and Survival

Fes/Fps: A Key Regulator of Cell Growth, Differentiation and Survival

Tyrosine-protein kinase (TPK) family member Fes/Fps (isoform 1) is a key regulator of cell growth, differentiation, and survival. It plays a crucial role in the development and maintenance of tissues, organs, and organs. Fes/Fps is a protein that is expressed in many different tissues throughout the body, including the brain, heart, kidneys, and intestine. Its functions include cell signaling, protein synthesis, DNA replication, and repair, as well as cell survival and growth regulation.

Fes/Fps is a member of the TPK family, which includes several other proteins that play a crucial role in regulating protein synthesis and cell signaling. The TPK family is characterized by the presence of a single transmembrane domain and a kinase domain, which is responsible for the protein's catalytic activity. The TPK family also includes a regulatory domain, which is responsible for regulating the activity of the protein.

Fes/Fps is a 21-kDa protein that is expressed in many different tissues throughout the body. It is highly conserved, with a calculated pI of 12.9 and a predicted localization in the cytoplasm. Fes/Fps is a good candidate for a drug target due to its unique structure and its involvement in several cellular processes.

One of the key functions of Fes/Fps is its role in cell signaling. Fes/Fps is involved in several signaling pathways, including the TGF-β pathway, the Wnt pathway, and the Hedgehog pathway. These pathways are responsible for regulating cellular processes such as cell growth, differentiation, and survival.

Fes/Fps is also involved in the regulation of protein synthesis. It functions as a protein kinase, which is responsible for regulating the activity of other proteins. Fes/Fps promotes the phosphorylation of several target proteins, which allows it to regulate their activity and function.

In addition to its role in cell signaling and protein synthesis, Fes/Fps is also involved in the regulation of cell survival and growth. It plays a role in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate themselves. Fes/Fps is also involved in the regulation of apoptosis, which is the process by which cells die and are removed from the body.

Fes/Fps is a critical protein that plays a crucial role in the regulation of cellular processes. Its unique structure and its involvement in several cellular processes make it an attractive candidate for drug targeting. Further research is needed to fully understand the functions of Fes/ Fps and its potential as a drug target.

Protein Name: FES Proto-oncogene, Tyrosine Kinase

Functions: Tyrosine-protein kinase that acts downstream of cell surface receptors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, cell attachment and cell spreading. Plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Acts down-stream of the activated FCER1 receptor and the mast/stem cell growth factor receptor KIT. Plays a role in the regulation of mast cell degranulation. Plays a role in the regulation of cell differentiation and promotes neurite outgrowth in response to NGF signaling. Plays a role in cell scattering and cell migration in response to HGF-induced activation of EZR. Phosphorylates BCR and down-regulates BCR kinase activity. Phosphorylates HCLS1/HS1, PECAM1, STAT3 and TRIM28

The "FES Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FES comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Fetal Hemoglobin (HbF) | FETUB | FEV | FEZ1 | FEZ2 | FEZF1 | FEZF1-AS1 | FEZF2 | FFAR1 | FFAR2 | FFAR3 | FFAR4 | FGA | FGB | FGD1 | FGD2 | FGD3 | FGD4 | FGD5 | FGD5-AS1 | FGD5P1 | FGD6 | FGF1 | FGF10 | FGF10-AS1 | FGF11 | FGF12 | FGF12-AS2 | FGF13 | FGF13-AS1 | FGF14 | FGF14-AS1 | FGF14-AS2 | FGF14-IT1 | FGF16 | FGF17 | FGF18 | FGF19 | FGF2 | FGF20 | FGF21 | FGF22 | FGF23 | FGF3 | FGF4 | FGF5 | FGF6 | FGF7 | FGF7P3 | FGF7P5 | FGF7P6 | FGF8 | FGF9 | FGFBP1 | FGFBP2 | FGFBP3 | FGFR1 | FGFR1OP2 | FGFR2 | FGFR3 | FGFR3P1 | FGFR4 | FGFRL1 | FGG | FGGY | FGL1 | FGL2 | FGR | FH | FHAD1 | FHDC1 | FHF Complex | FHIP1A | FHIP1B | FHIP2A | FHIP2B | FHIT | FHL1 | FHL2 | FHL3 | FHL5 | FHOD1 | FHOD3 | FIBCD1 | FIBIN | FIBP | Fibrinogen | Fibroblast growth factor (FGF) | Fibroblast Growth Factor Receptor (FGFR) | Fibronectin Type III Domain | FICD | FIG4 | FIGLA | FIGN | FIGNL1 | FIGNL2 | FILIP1 | FILIP1L | FILNC1 | FIP1L1